IPercept Raises $16.5 Million in Series A Funding
IPercept, a Stockholm-based company specializing in machine health monitoring technology, has announced the successful closing of its Series A funding round, raising $16.5 million. The round was led by Isogon Ventures and 2150, with participation from Luminar Ventures, RunwayFBU, J12 Venture, and AI.Fund.
What IPercept Does
IPercept offers a unique solution for monitoring the health of CNC machines. Their patented device can be installed on the moving side of a machine in just a few hours, without any need for controller integration or extensive IT projects. This technology provides component-level health insights for over 50 different machine brands.
Leadership and Vision
The company was founded by Karoly Szipka, who also serves as the CEO, and Peter Troll, the Head of IoT Development. The leadership team is focused on expanding the company’s reach and improving the technology further.
Plans for the New Funding
The fresh capital will be strategically used to launch IPercept's operations in the United States. This expansion includes making initial hires locally and enhancing the company’s existing technology to better serve a global market.
Szipka commented on the funding round, expressing that the investment will significantly assist in scaling their operations and tech capabilities.
Investors' Perspective
Leading the investment, Isogon Ventures and 2150 are joined by other notable investors such as Luminar Ventures, RunwayFBU, J12 Venture, and AI.Fund. Their involvement underscores a strong belief in IPercept's potential to innovate within the industrial machinery sector.
Conclusion
With this substantial financial boost, IPercept is poised to make significant strides in the global market, particularly with its planned entry into the US. The company's innovative approach to machine health monitoring continues to attract attention and investment from leading venture firms.